Literature DB >> 9121777

Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and intron primers.

S Takenoshita1, M Tani, M Nagashima, K Hagiwara, W P Bennett, J Yokota, C C Harris.   

Abstract

Mutations in the transforming growth factor beta type II receptor (TGFbeta RII) gene have been detected in several human cancers exhibiting microsatellite instability. To extend analyses of this gene, we previously investigated the exon-intron organization of the TGFbeta RII gene and defined seven exons and flanking intron sequences. In this study, we further determined the nucleotide sequences surrounding these seven exons and designed eight sets of intron-based primers to examine the entire coding region of the TGFbeta RII gene. Using these primers, we screened genomic DNA sequences from 30 sporadic colorectal cancers for mutations of the TGFbeta RII gene. TGFbeta RII mutations were detected in two of 30 tumors and both displayed microsatellite instability. One had a deletion in a polyadenine tract in exon 3 and the other had a point mutation in the kinase domain located in exon 7. There were no mutations in exons 1, 2, 4, 5 and 6. These results further implicate the polyadenine tract and kinase domain as mutational hotspots in the TGFbeta RII gene in cells with genomic instability and suggest that TGFbeta RII gene mutations occur rarely in cells lacking genomic instability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9121777     DOI: 10.1038/sj.onc.1200938

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

Authors:  M A Lynch; T A Petrel; H Song; T J Knobloch; B C Casto; D Ramljak; L M Anderson; V DeGroff; G D Stoner; R W Brueggemeier; C M Weghorst
Journal:  Gene Expr       Date:  2001

2.  Alternative genetic pathways in colorectal carcinogenesis.

Authors:  S Olschwang; R Hamelin; P Laurent-Puig; B Thuille; Y De Rycke; Y J Li; F Muzeau; J Girodet; R J Salmon; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 3.  Targeting TGF-β signaling in cancer.

Authors:  Lior H Katz; Ying Li; Jiun-Sheng Chen; Nina M Muñoz; Avijit Majumdar; Jian Chen; Lopa Mishra
Journal:  Expert Opin Ther Targets       Date:  2013-05-07       Impact factor: 6.902

4.  Ras-mediated suppression of TGFbetaRII expression in intestinal epithelial cells involves Raf-independent signaling.

Authors:  N M Bulus; H M Sheng; N Sizemore; S M Oldham; J V Barnett; R J Coffey; D R Beauchamp; J A Barnard
Journal:  Neoplasia       Date:  2000 Jul-Aug       Impact factor: 5.715

5.  Transforming growth factor beta stimulation of colorectal cancer cell lines: type II receptor bypass and changes in adhesion molecule expression.

Authors:  M Ilyas; J A Efstathiou; J Straub; H C Kim; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers.

Authors:  June A Chia; Lisa A Simms; Sarah-Jane Cozzi; Joanne Young; Jeremy R Jass; Michael D Walsh; Kevin J Spring; Barbara A Leggett; Vicki L J Whitehall
Journal:  BMC Cancer       Date:  2006-10-24       Impact factor: 4.430

Review 7.  Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy.

Authors:  Yhun Yhong Sheen; Min-Jin Kim; Sang-A Park; So-Yeon Park; Jeong-Seok Nam
Journal:  Biomol Ther (Seoul)       Date:  2013-09-30       Impact factor: 4.634

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.